Signaling pathways regulating vascular smooth muscle cell differentiation

Vascular

Volumn 17, Issue SUPPL. 1, 2009, Pages

  Rzucidlo, Eva M ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; SOMATOMEDIN C; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE; SIGNAL PEPTIDE;

ANEURYSM; ANGIOGENESIS; ARTERY INTIMA PROLIFERATION; ASTHMA; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; COLLATERAL CIRCULATION; HUMAN; HYPERTENSION; MOLECULAR MECHANICS; PHENOTYPE; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; ANIMAL; CARDIOVASCULAR DISEASE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SMOOTH MUSCLE FIBER;

ANIMALS; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 70349250221     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.2310/6670.2008.00089     Document Type: Review

References (47)

1. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995;75:487-517.
2. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004;84:767-801.
3. Sobue K, Hayashi K, Nishida W. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem 1999;190:105-18.
4. Au YP, Kenagy RD, Clowes MM, Clowes AW. Mechanisms of inhibition by heparin of vascular smooth muscle cell proliferation and migration. Haemostasis 1993;23 Suppl 1:177-82.
5. Karnovsky MJ, Wright TC Jr, Castellot JJ Jr, et al. Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis. Ann N Y Acad Sci 1989;556:268-81.
6. Orlandi A, Ropraz P, Gabbiani G. Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-beta 1 and heparin. Exp Cell Res 1994;214:528-36.
7. Cook CL, Weiser MC, Schwartz PE, et al. Developmentally timed expression of an embryonic growth phenotype in vascular smooth muscle cells. Circ Res 1994;74:189-96.
8. Owens GK, Thompson MM. Developmental changes in isoactin expression in rat aortic smooth muscle cells in vivo. Relationship between growth and cytodifferentiation. J Biol Chem 1986;261: 13373-80.
9. O'Brien ER, Alpers CE, Stewart DK, et al. Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. Circ Res 1993;73:223-31.
10. Wilcox JN. Analysis of local gene expression in human atherosclerotic plaques. J Vasc Surg 1992;15:913-6.
11. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest 1983;49:208-15.
12. Newby AC, Zaltsman AB. Molecular mechanisms in intimal hyperplasia. J Pathol 2000;190:300-9.
13. Marx SO, Marks AR. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation 2001; 104:852-5.
14. Shah PK, Falk E, Badimon JJ, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995;92:1565-9.
15. Folkman J, D'Amore PA. Blood vessel formation: what is its molecular basis? Cell 1996;87:1153-5.
16. Hirschi KK, Rohovsky SA, D'Amore PA. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 1998;141:805-14.
17. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-4.
18. Heilmann C, Beyersdorf F, Lutter G. Collateral growth: cells arrive at the construction site. Cardiovasc Surg 2002;10:570-8.
19. Hayashi K, Saga H, Chimori Y, et al. Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase. J Biol Chem 1998;273:28860-7.
20. Hayashi K, Takahashi M, Kimura K, et al. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J Cell Biol 1999;145:727-40.
21. Martin KA, Merenick BL, Ding M, et al. Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/ phosphatidylinositol 3-kinase/Akt2 feedback signaling. J Biol Chem 2007;282:36112-20.
22. Force T, Bonventre JV. Growth factors and mitogen-activated protein kinases. Hypertension 1998;31(1 Pt 2):152-61.
23. Pyles JM, March KL, Franklin M, et al. Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries. Circ Res 1997;81:904-10.
24. Larrivee JF, Bachvarov DR, Houle F, et al. Role of the mitogen-activated protein kinases in the expression of the kinin B1 receptors induced by tissue injury. J Immunol 1998;160:1419-26.
25. Zou Y, Qi Y, Roztocil E, et al. Patterns of kinase activation induced by injury in the murine femoral artery. J Surg Res 2007;142:332-40.
26. Rommel C, Clarke BA, Zimmermann S, et al. Differentiation stagespecific inhibition of the Raf-MEK-ERK pathway by Akt. Science 1999;286:1738-41.
27. Zimmermann S, Moelling K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 1999;286:1741-4.
28. Reusch HP, Schaefer M, Plum C, et al. Gbeta gamma mediate differentiation of vascular smooth muscle cells. J Biol Chem 2001; 276:19540-7.
29. Hixon ML, Muro-Cacho C, Wagner MW, et al. Akt1/PKB upregulation leads to vascular smooth muscle cell hypertrophy and polyploidization. J Clin Invest 2000;106:1011-20.
30. Yang ZZ, Tschopp O, Hemmings-Mieszczak M, et al. Protein kinase B alpha/ Akt1 regulates placental development and fetal growth. J Biol Chem 2003;278:32124-31.
31. Cho H, Mu J, Kim JK, et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001;292:1728-31.
32. Gingras AC, Raught B, Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev 2001;15:807-26.
33. Jefferies HB, Fumagalli S, Dennis PB, et al. Rapamycin suppresses 59TOP mRNA translation through inhibition of p70s6k. EMBO J 1997;16:3693-704.
34. Gingras AC, Raught B, Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 1999;68:913-63.
35. Harrington LS, Findlay GM, Lamb RF. Restraining PI3K: mTOR signalling goes back to the membrane. Trends Biochem Sci 2005; 30:35-42.
36. Tremblay F, Krebs M, Dombrowski L, et al. Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes 2005;54:2674-84.
37. Um SH, D'Alessio D, Thomas G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab 2006;3:393-402.
38. Eisenberg MJ, Konnyu KJ. Review of randomized clinical trials of drug-eluting stents for the prevention of in-stent restenosis. Am J Cardiol 2006;98:375-82.
39. Moliterno DJ. Healing Achilles - sirolimus versus paclitaxel. N Engl J Med 2005;353:724-7.
40. Marx SO, Jayaraman T, Go LO, Marks AR. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 1995;76:412-7.
41. Poon M, Marx SO, Gallo R, et al. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 1996;98: 2277-83.
42. Gallo R, Padurean A, Jayaraman T, et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 1999;99: 2164-70.
43. Martin KA, Rzucidlo E, Merenick B, et al. The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. Am J Physiol Cell Physiol 2004;286:507-17.
44. Ozes ON, Akca H, Mayo LD, et al. A phosphatidylinositol 3- kinase/Akt/ mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc Natl Acad Sci U S A 2001;98: 4640-5.
45. Tremblay F, Marette A. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem 2001;276:38052-60.
46. Um SH, Frigerio F, Watanabe M, et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 2004;431:200-5.
47. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006;48: 2584-91.